| P2093 | author name string | Guangyu Li | |
| | Monique R Ferguson | |
| | Brian Friedrich | |
| | Natallia Dziuba | |
| P2860 | cites work | Genotypic and phenotypic characterization of HIV-1 patients with primary infection | Q22242245 |
| | Identification of host proteins required for HIV infection through a functional genomic screen | Q24306298 |
| | Global analysis of host-pathogen interactions that regulate early-stage HIV-1 replication | Q29616375 |
| | The role of mononuclear phagocytes in HTLV-III/LAV infection | Q29618676 |
| | Kinetics of human immunodeficiency virus type 1 (HIV) DNA integration in acutely infected cells as determined using a novel assay for detection of integrated HIV DNA. | Q33849497 |
| | HIV-1 replication is controlled at the level of T cell activation and proviral integration | Q33919765 |
| | Increased susceptibility of differentiated mononuclear phagocytes to productive infection with human immunodeficiency virus-1 (HIV-1) | Q35596389 |
| | Multiple effects of mutations in human immunodeficiency virus type 1 integrase on viral replication | Q35838477 |
| | Integration is required for productive infection of monocyte-derived macrophages by human immunodeficiency virus type 1. | Q35839212 |
| | Human immunodeficiency virus type 1 replication is blocked prior to reverse transcription and integration in freshly isolated peripheral blood monocytes | Q35861719 |
| | Cofactor requirement for human immunodeficiency virus type 1 entry into a CD4-expressing human cell line | Q36653358 |
| | Circularization of human immunodeficiency virus type 1 DNA in vitro | Q36828935 |
| | A more precise HIV integration assay designed to detect small differences finds lower levels of integrated DNA in HAART treated patients | Q37030314 |
| | Detecting HIV-1 integration by repetitive-sampling Alu-gag PCR. | Q37386023 |
| | Macrophages: do they impact AIDS progression more than CD4 T cells? | Q37669572 |
| | HIV-1 tropism for mononuclear phagocytes can be determined by regions of gp120 outside the CD4-binding domain | Q39313963 |
| | Human immunodeficiency virus type 1 in the semen of men receiving highly active antiretroviral therapy | Q39625779 |
| | A sensitive, quantitative assay for human immunodeficiency virus type 1 integration | Q39685335 |
| | Potential role for CD63 in CCR5-mediated human immunodeficiency virus type 1 infection of macrophages | Q39732524 |
| | Integration is essential for efficient gene expression of human immunodeficiency virus type 1. | Q40044176 |
| | Human immunodeficiency virus type 1 2-LTR circles reside in a nucleoprotein complex which is different from the preintegration complex. | Q40048140 |
| | Requirement of active human immunodeficiency virus type 1 integrase enzyme for productive infection of human T-lymphoid cells | Q40062287 |
| | Analysis of human immunodeficiency virus type 1 integration by using a specific, sensitive and quantitative assay based on real-time polymerase chain reaction | Q40307039 |
| | A quantitative assay for HIV DNA integration in vivo | Q40809319 |
| | Indicator cell lines for detection of primary strains of human and simian immunodeficiency viruses | Q41104028 |
| | Discovery of raltegravir, a potent, selective orally bioavailable HIV-integrase inhibitor for the treatment of HIV-AIDS infection | Q46396658 |
| | Antiretroviral therapy with the integrase inhibitor raltegravir alters decay kinetics of HIV, significantly reducing the second phase | Q46843159 |
| P304 | page(s) | 354 | |
| P577 | publication date | 2010-12-03 | |
| P1433 | published in | Virology Journal | Q7934868 |
| P1476 | title | Quantitative PCR used to assess HIV-1 integration and 2-LTR circle formation in human macrophages, peripheral blood lymphocytes and a CD4+ cell line | |
| P478 | volume | 7 | |